The burgeoning field ofstudies" into novel anxiolytics is rapidly expanding, with novel research chemicals showing promising results in preclinical and clinical trials. These molecules often exhibit distinct mechanisms of action compared to traditional anti-anxiety medications, offering potential benefits for patients struggling with anxiety disord